News

BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass., February 29, 2024--BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced a new matching adjusted ...